Close Menu

Agilent

Agilent has partnered with the National University of Singapore and National University Hospital to establish the S$38 million ($27.4 million) research and development facility in Singapore.

The firm's diagnostics and genomics group saw an 11 percent year-over-year revenue increase in the third quarter.

The diagnostic can now be used to identify patients with esophageal squamous cell carcinoma who may benefit from first-line treatment with Keytruda.

The diagnostic can now be used to identify patients with head and neck squamous cell carcinoma who may benefit from first-line treatment with Keytruda.

The investment bank gave Danaher a Neutral rating and a $148 price target on the firm's shares, while it gave Agilent an Overweight rating with an $83 price target.

The diagnostic can now be used to identify a wider range of patients with stage III or metastatic NSCLC who may benefit from first-line treatment with Keytruda.

Hologic said this week that it has opened a Learning and Experience Centre in Zaventem, Belgium. The 1,500-square-meter facility provides training for customers, healthcare professionals, and employees across its Europe, Middle East, and Africa region.

UBS granted Agilent a Buy rating and a $92 price target, and Qiagen a Neutral rating with a $42 price target.

The firm's diagnostics and genomics group saw a 13 percent year-over-year revenue increase in the first quarter.

Pages